Investing.com - Venus Concept Inc (NASDAQ: VERO) reported first quarter EPS of $-0.140, $0.01 worse than the analyst estimate of $-0.130. Revenue for the quarter came in at $24.3M...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Consumer Goods, Technology and Utilities sectors propelled shares higher. At the close in...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. Its products and services include main console and applicators/handpieces, marketing supplies and kits, consumables and disposables, replacement applicators/handpieces, and others. It has developed and commercialized 11 technology platforms, including its ARTAS and NeoGraft systems. Its medical aesthetic technology platform is for a variety of indications, including treatment of facial wrinkles in certain skin types, temporary reduction of appearance of cellulite, non-invasive fat reduction (lipolysis) in the abdomen and flanks for certain body types and relief of minor muscle aches and pains in jurisdictions around the world. Venus Viva, Venus Viva MD, Venus Legacy, Venus Concept, Venus Versa, Venus Fiore, Venus Freedom, and others are trademarks of the Company.
|Moving Averages||Strong Buy||Strong Buy||Strong Buy||Neutral||Strong Sell|
|Technical Indicators||Strong Buy||Buy||Buy||Buy||Strong Sell|
|Summary||Strong Buy||Strong Buy||Strong Buy||Neutral||Strong Sell|